The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada

2017 ◽  
Vol 90 (3) ◽  
pp. 592-598 ◽  
Author(s):  
Marc Steben ◽  
Najwa Ouhoummane ◽  
Caroline Rodier ◽  
Liliya Sinyavskaya ◽  
Paul Brassard
2019 ◽  
Vol 46 (4) ◽  
pp. 213-220 ◽  
Author(s):  
Anthony E. Yakely ◽  
Lital Avni-Singer ◽  
Carlos R. Oliveira ◽  
Linda M. Niccolai

2016 ◽  
Vol 29 (2) ◽  
pp. 101 ◽  
Author(s):  
Ana Gameiro ◽  
João Alves ◽  
Irene Santo ◽  
Jacinta Azevedo

<p><strong>Introduction:</strong> Human papillomavirus infection is the most common sexual transmitted infection in the world, being associated with different diseases, namely anogenital warts, recurrent respiratory papillomatosis and anal, cervical, and oropharyngeal cancers. Among sexually active people, approximately 1% has anogenital warts, 90% of cases resulting from genotypes 6 and 11.<br /><strong>Material and Methods:</strong> Patients diagnosed with first episode of anogenital warts from 2008 to 2014 in Lisbon’s major venereology clinic were identified, and characterized according to sex, sexual orientation, age, warts location, and number of sexual partners. <br /><strong>Results:</strong> We observed a statistically significant decrease in first anogenital warts diagnosis among &lt; 19 year old females (r = -0.848;<br />p = 0.016) and a non-statistically significant decrease among &lt; 19 – year-old males and among 20 – 24 year old females.<br /><strong>Discussion:</strong> In October 2008, the quadrivalent vaccine (genotypes 6, 11, 16, 18) was introduced in the Portuguese national vaccination program, targeting 13-year-old females, with a catch-up for 17 year old females. In the women´s group, decrease in first anogenital warts diagnosis is probably related to human papillomavirus vaccination before onset of sexual activity.<br /><strong>Conclusion:</strong> This study reinforces the importance of national human papillomavirus vaccination program.</p>


2013 ◽  
Vol 40 (1) ◽  
pp. 28-31 ◽  
Author(s):  
Rafael T. Mikolajczyk ◽  
Angela A. Kraut ◽  
Johannes Horn ◽  
Renate Schulze-Rath ◽  
Edeltraut Garbe

Sexual Health ◽  
2010 ◽  
Vol 7 (1) ◽  
pp. 55 ◽  
Author(s):  
Elizabeth A. Sturgiss ◽  
Fengyi Jin ◽  
Sarah J. Martin ◽  
Andrew Grulich ◽  
Francis J. Bowden

Background: Anogenital warts are a common initial presentation to the Canberra Sexual Health Centre. It is anticipated that the introduction of human papillomavirus vaccination will reduce the incidence of anogenital warts. The present study determines the prevalence of other sexually transmissible infections in patients newly diagnosed with warts who may not have presented for screening without the impetus of a genital lump. Methods: The prevalence of other sexually transmissible infections in new patients presenting to the Canberra Sexual Health Centre diagnosed with anogenital warts was determined from a retrospective clinical audit from 2002 to 2007. Results: A total of 1015 new patients were diagnosed with anogenital warts. Of this total cohort, 53 (5.2%) were found to be co-infected with either chlamydia and/or gonorrhoea. Only 13.2% of co-infected patients reported symptoms other than genital lumps. Of co-infected patients 11.3% reported contact with a partner with chlamydia and/or gonorrhoea. Not all patients were screened for other sexually transmissible infections: 762 (75.1%) were screened for chlamydia and 576 (56.7%) were screened for gonorrhoea. Of those tested, 6.8% of men and 6.9% of women were positive for chlamydia highlighting the importance of offering full sexually transmissible infection screening in those newly diagnosed with anogenital warts. Chlamydia was more common in younger patients who reported a higher number of sexual partners. Conclusions: It is anticipated that human papillomavirus vaccination will lead to a decline in anogenital wart incidence as well as other human papillomavirus associated disease. Although one opportunity for testing for other sexually transmissible infections may be lost in this population, the decrease in anogenital warts will leave clinicians with more time to pursue other screening programs. Education and screening campaigns should continue to focus on the asymptomatic nature of the majority of sexually transmissible infections.


2018 ◽  
Vol 45 (4) ◽  
pp. 254-259 ◽  
Author(s):  
Karla Willows ◽  
Songul Bozat-Emre ◽  
Christiaan H. Righolt ◽  
Erich V. Kliewer ◽  
Salaheddin M. Mahmud

Sign in / Sign up

Export Citation Format

Share Document